• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.

作者信息

Limami Youness, Khalki Loubna, Zaid Nabil, Khyatti Meriem, Turk Joumana El, Ammara Mounia, Mtairag El Mostafa, Oudghiri Mounia, Naya Abdallah, Taberkant Mustapha, Zaid Younes

机构信息

Research Center of Abulcasis, University of Health Sciences, Cheikh Zaïd Hospital, Rabat, Morocco.

Department of Biology, Immunology and Biodiversity Laboratory, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.

出版信息

Semin Thromb Hemost. 2022 Feb;48(1):109-111. doi: 10.1055/s-0041-1728831. Epub 2021 May 10.

DOI:10.1055/s-0041-1728831
PMID:33971677
Abstract
摘要

相似文献

1
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.牛津大学-阿斯利康ChAdOx1新冠疫苗不会改变血小板聚集。
Semin Thromb Hemost. 2022 Feb;48(1):109-111. doi: 10.1055/s-0041-1728831. Epub 2021 May 10.
2
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.腺病毒载体新冠疫苗（ChAdOx1 nCoV-19）接种后发生急性脱髓鞘性多发神经根神经病伴双侧面瘫 1 例。
Neurol Sci. 2021 Nov;42(11):4747-4749. doi: 10.1007/s10072-021-05467-w. Epub 2021 Jul 17.
3
Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.新型冠状病毒牛津阿斯利康疫苗接种后出现的大疱性斯威特综合征。
Br J Dermatol. 2022 Mar;186(3):e110. doi: 10.1111/bjd.20876. Epub 2021 Nov 24.
4
Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine.牛津-阿斯利康新冠疫苗接种后出现的扁平苔藓样疹
J Cosmet Dermatol. 2022 Mar;21(3):883-885. doi: 10.1111/jocd.14738. Epub 2022 Jan 8.
5
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
6
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.接种ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生的自身免疫性肝炎。
J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.
7
Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.单剂量牛津-阿斯利康新冠疫苗，随后进行12周的加强针接种。
Lancet. 2021 Mar 6;397(10277):854-855. doi: 10.1016/S0140-6736(21)00528-6.
8
Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh.从孟加拉国西南部接受 ChAdOx1 nCoV-19 免疫的患者中鉴定出的关注的 SARS-CoV-2 变体的基因组分析。
J Infect Public Health. 2022 Feb;15(2):156-163. doi: 10.1016/j.jiph.2021.12.002. Epub 2021 Dec 7.
9
Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin.异源加强 COVID-19 疫苗接种方案的免疫原性和安全性：ChAdOx1 疫苗 Covishield 加 BBV152 疫苗 Covaxin。
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab166.
10
Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.老年女性接种牛津-阿斯利康 COVID-19 疫苗（AZD1222）后出现 Sweet 综合征。
Dermatol Ther. 2021 Nov;34(6):e15146. doi: 10.1111/dth.15146. Epub 2021 Oct 7.

引用本文的文献

1
Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development.基于灭活新冠病毒疫苗的异源加强免疫可增强体液免疫并促进BCR库发育。
Vaccines (Basel). 2024 Jan 24;12(2):120. doi: 10.3390/vaccines12020120.
2
People having hematological disorders and hypercoagulability state need extra precautions because of the increased risk of thrombosis after COVID-19 vaccination.患有血液系统疾病和高凝状态的人由于在接种新冠疫苗后发生血栓形成的风险增加，需要格外注意。
Front Med (Lausanne). 2023 Feb 14;9:1082611. doi: 10.3389/fmed.2022.1082611. eCollection 2022.
3
Platelet Activation and Cytokine Release of Interleukin-8 and Interferon-Gamma-Induced Protein 10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection.
ChAdOx1 nCoV-19冠状病毒疫苗注射后血小板活化及白细胞介素-8和干扰素-γ诱导蛋白10的细胞因子释放
Vaccines (Basel). 2023 Feb 16;11(2):456. doi: 10.3390/vaccines11020456.
4
Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study.四种 COVID-19 疫苗对血小板活化、凝血和炎症的头对头比较。TREASURE 研究。
Thromb Res. 2023 Mar;223:24-33. doi: 10.1016/j.thromres.2023.01.015. Epub 2023 Jan 18.
5
Maintenance of Antibody Response in Egyptian Healthcare Workers Vaccinated with ChAdOx1 nCoV-19 Vaccine during Delta and Omicron Variants Pandemic: A Prospective Study.埃及医护人员接种ChAdOx1 nCoV-19疫苗后在德尔塔和奥密克戎变异株大流行期间抗体反应的维持：一项前瞻性研究
Vaccines (Basel). 2022 Oct 12;10(10):1706. doi: 10.3390/vaccines10101706.
6
ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin-6.ChAdOx1疫苗接种、血液凝固与炎症：对凝血无影响，但白细胞介素-6增加。
Res Pract Thromb Haemost. 2021 Dec 7;5(8):e12630. doi: 10.1002/rth2.12630. eCollection 2021 Dec.